Federal Supply Schedule 36F79725D031E

Award Date 5/4/25
Last Date to Order 10/31/25
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Valinor Pharma, LLC, a for-profit limited liability company. The contract is a multiple award, non-set-aside agreement with a ceiling value of $25,000.00 and a period of performance through October 17, 2023. The contract is an "Interim Agreement" issued under Federal Supply Schedule 65 I B, which covers Drugs, Pharmaceuticals, & Hematology Related...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs, Veterans Integrated Service Network 12, to Aquestive Therapeutics, Inc., a for-profit manufacturer of goods and subchapter S corporation. The contract, which has a maximum value of $25,000.00 and a period of performance through March 31, 2025, provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract is a multiple...
This Federal Supply Schedule contract award, with a ceiling value of $48,300,000.00, was made by the Veterans Integrated Service Network 12 (VISN 12) to Tersera Therapeutics LLC, a for-profit limited liability company manufacturer of goods. The contract, which has a period of performance ending on March 14, 2029, is for the delivery of Drugs, Pharmaceuticals, & Hematology Related Products under the 65 I B Federal Supply Schedule category. As a multiple award Federal Supply Schedule contract,...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian U.S. federal agency, to Spectrum Pharmaceuticals, Inc., a for-profit manufacturer. The contract, with a ceiling value of $25,000.00, is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract period of performance extends from the award date of December 16, 2022 to the ultimate completion...
The Federal Supply Schedule contract 36F79721D0183 was awarded by the Veterans Integrated Service Network 12 (VISN 12) to Akebia Therapeutics, Inc., a for-profit manufacturer, to provide pharmaceuticals and drugs under the FSS-61-IB Pharmaceuticals and Drugs Master Schedule. This multiple-award contract has a total ceiling value of $40,190,500.00 and a period of performance through June 30, 2026. The contract aims to procure a range of pharmaceutical and hematology-related products to support...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Long Grove Pharmaceuticals, LLC, provides for the delivery of drugs, pharmaceuticals, and hematology-related products over a period of approximately 5 years, from April 1, 2023 to March 31, 2028. The contract has a ceiling value of $2,072,700.00 and is a multiple award vehicle, meaning multiple contractors may be awarded the opportunity to provide these products...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Springworks Therapeutics, Inc. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through April 14, 2024. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows government agencies to procure these...
  • 36F79725D031E
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements

The Federal Supply Schedule contract awarded to Soleno Therapeutics Inc. by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs is an interim agreement under Schedule 65 IB for Drugs, Pharmaceuticals, and Hematology Related Products. The $25,000 multiple-award contract has a period of performance through October 31, 2025. As a for-profit manufacturer, Soleno Therapeutics Inc. will provide pharmaceutical and related medical products to VISN 12, which serves veterans in several Midwest states. While no specific product details are provided, the contract scope is focused on procuring drugs, pharmaceuticals, and hematology supplies to support VISN 12's healthcare services for eligible veterans. The contract was awarded on a non-set-aside basis, allowing both small and large businesses to compete.

Generated 5/4/25, 12:53 AM